Septic Cardiomyopathy

Critical Care Medicine

Volumn 46, Issue 4, 2018, Pages 625-634

  Beesley, Sarah J ^a,b   Weber, Gerhard ^c   Sarge, Todd ^d   Nikravan, Sara ^e   Grissom, Colin K ^a,b   Lanspa, Michael J ^a   Shahul, Sajid ^f   Brown, Samuel M ^a,b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

cardiac dysfunction; sepsis; septic cardiomyopathy

Indexed keywords

NITRIC OXIDE; BIOLOGICAL MARKER;

CARDIAC INDEX; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; HEART EJECTION FRACTION; HEART PERFORMANCE; HEART RATE; HEMODYNAMICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; INTENSIVE CARE UNIT; MORTALITY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SEPSIS; SPECKLE TRACKING ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW; COMPLICATION; ORGAN DYSFUNCTION SCORE; SEPTIC SHOCK;

BIOMARKERS; CARDIOMYOPATHIES; ELECTROCARDIOGRAPHY; HEMODYNAMICS; HUMANS; ORGAN DYSFUNCTION SCORES; PREVALENCE; PROGNOSIS; SEPSIS; SHOCK, CARDIOGENIC; SHOCK, SEPTIC;

EID: 85051006745     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002851     Document Type: Review

References (133)

1. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840–851
2. Singer M, Deutschman CS, Seymour CW, et al: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801–810
3. Abraham E, Singer M: Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007; 35:2408–2416
4. Blanco J, Muriel-Bombín A, Sagredo V, et al; Grupo de Estudios y Análisis en Cuidados Intensivos: Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study. Crit Care 2008; 12:R158
5. Vieillard-Baron A: Septic cardiomyopathy. Ann Intensive Care 2011; 1:6
6. Court O, Kumar A, Parrillo JE, et al: Clinical review: Myocardial depression in sepsis and septic shock. Crit Care 2002; 6:500–508
7. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock. Crit Care Clin 2000; 16:251–287
8. Flierl MA, Rittirsch D, Huber-Lang MS, et al: Molecular events in the cardiomyopathy of sepsis. Mol Med 2008; 14:327–336
9. Zhang Z, Dai H, Yu Y, et al: Elevated pregnancy-associated plasma protein A predicts myocardial dysfunction and death in severe sepsis. Ann Clin Biochem 2014; 51(Pt 1):22–29
10. Endo T, Kushimoto S, Yamanouchi S, et al; PiCCO Pulmonary Edema Study Group: Limitations of global end-diastolic volume index as a parameter of cardiac preload in the early phase of severe sepsis: A subgroup analysis of a multicenter, prospective observational study. J Intensive Care 2013; 1:11
11. Etchecopar-Chevreuil C, François B, Clavel M, et al: Cardiac morphological and functional changes during early septic shock: A transesophageal echocardiographic study. Intensive Care Med 2008; 34:250–256
12. Vieillard-Baron A, Caille V, Charron C, et al: Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36:1701–1706
13. Klouche K, Pommet S, Amigues L, et al: Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: Relationships with systolic myocardial dysfunction and intensive care unit mortality. J Intensive Care Med 2014; 29:229–237
14. Meng JB, Hu MH, Lai ZZ, et al: Levosimendan versus dobutamine in myocardial injury patients with septic shock: A randomized controlled trial. Med Sci Monit 2016; 22:1486–1496
15. Repessé X, Charron C, Vieillard-Baron A: Evaluation of left ventricular systolic function revisited in septic shock. Crit Care 2013; 17:164
16. Sevilla Berrios RA, O’Horo JC, Velagapudi V, et al: Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: A systematic review and meta-analysis. J Crit Care 2014; 29:495–499
17. Lanspa MJ, Pittman JE, Hirshberg EL, et al: Association of left ventricular longitudinal strain with central venous oxygen saturation and serum lactate in patients with early severe sepsis and septic shock. Crit Care 2015; 19:304
18. Dalla K, Hallman C, Bech-Hanssen O, et al: Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction. Cardiovasc Ultrasound 2015; 13:30
19. Bouhemad B, Nicolas-Robin A, Arbelot C, et al: Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009; 37:441–447
20. Charpentier J, Luyt CE, Fulla Y, et al: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32:660–665
21. Shahul S, Gulati G, Hacker MR, et al: Detection of myocardial dysfunction in septic shock: A speckle-tracking echocardiography study. Anesth Analg 2015; 121:1547–1554
22. De Geer L, Engvall J, Oscarsson A: Strain echocardiography in septic shock - a comparison with systolic and diastolic function parameters, cardiac biomarkers and outcome. Crit Care 2015; 19:122
23. Orde SR, Pulido JN, Masaki M, et al: Outcome prediction in sepsis: Speckle tracking echocardiography based assessment of myocardial function. Crit Care 2014; 18:R149
24. Pulido JN, Afessa B, Masaki M, et al: Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc 2012; 87:620–628
25. Landesberg G, Gilon D, Meroz Y, et al: Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 2012; 33:895–903
26. Brown SM, Pittman JE, Hirshberg EL, et al: Diastolic dysfunction and mortality in early severe sepsis and septic shock: A prospective, observational echocardiography study. Crit Ultrasound J 2012; 4:8
27. Rolando G, Espinoza ED, Avid E, et al: Prognostic value of ventricular diastolic dysfunction in patients with severe sepsis and septic shock. Rev Bras Ter Intensiva 2015; 27:333–339
28. Gillebert TC, Leite-Moreira AF, De Hert SG: Load dependent diastolic dysfunction in heart failure. Heart Fail Rev 2000; 5:345–355
29. Lanspa MJ, Gutsche AR, Wilson EL, et al: Application of a simplified definition of diastolic function in severe sepsis and septic shock. Crit Care 2016; 20:243
30. Nizamuddin J, Mahmood F, Tung A, et al: Interval changes in myocardial performance index predict outcome in severe sepsis. J Cardiothorac Vasc Anesth 2017; 31:957–964
31. Tei C, Nishimura RA, Seward JB, et al: Noninvasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10:169–178
32. Werdan K, Oelke A, Hettwer S, et al: Septic cardiomyopathy: Hemodynamic quantification, occurrence, and prognostic implications. Clin Res Cardiol 2011; 100:661–668
33. Guarracino F, Ferro B, Morelli A, et al: Ventriculoarterial decoupling in human septic shock. Crit Care 2014; 18:R80
34. Guarracino F, Baldassarri R, Pinsky MR: Ventriculo-arterial decoupling in acutely altered hemodynamic states. Crit Care 2013; 17:213
35. Schulman DS, Biondi JW, Matthay RA, et al: Effect of positive end-expiratory pressure on right ventricular performance. Importance of baseline right ventricular function. Am J Med 1988; 84:57–67
36. Price LC, Wort SJ, Finney SJ, et al: Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: a systematic literature review. Crit Care 2010; 14:R169
37. Arbo JE, Maslove DM, Beraud AS: Bedside assessment of right atrial pressure in critically ill septic patients using tissue Doppler ultrasonography. J Crit Care 2013; 28:1112.e1–1112.e5
38. Landesberg G, Jaffe AS, Gilon D, et al: Troponin elevation in severe sepsis and septic shock: The role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med 2014; 42:790–800
39. Fernandes CJ Jr, Akamine N, Knobel E: Cardiac troponin: A new serum marker of myocardial injury in sepsis. Intensive Care Med 1999; 25:1165–1168
40. Papanikolaou J, Makris D, Mpaka M, et al: New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care 2014; 18:R94
41. Maeder M, Fehr T, Rickli H, et al: Sepsis-associated myocardial dysfunction: Diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006; 129:1349–1366
42. Post F, Weilemann LS, Messow CM, et al: B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med 2008; 36:3030–3037
43. Pirracchio R, Deye N, Lukaszewicz AC, et al: Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 2008; 36:2542–2546
44. Witthaut R, Busch C, Fraunberger P, et al: Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: Impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 2003; 29:1696–1702
45. Mouncey PR, Osborn TM, Power GS, et al; ProMISe Trial Investigators: Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372:1301–1311
46. Yealy DM, Kellum JA, Huang DT, et al; ProCess Investigators: A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370:1683–1693
47. Peake SL, Delaney A, Bailey M, et al; Arise Investigators and Anzics Clinical Trials Group: Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371:1496–1506
48. Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717–1722
49. Morelli A, Ertmer C, Westphal M, et al: Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA 2013; 310:1683–1691
50. Schmittinger CA, Dünser MW, Haller M, et al: Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression. Crit Care 2008; 12:R99
51. Calvin JE, Driedger AA, Sibbald WJ: An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. Chest 1981; 80:579–586
52. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483–490
53. Parker MM, Shelhamer JH, Natanson C, et al: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis. Crit Care Med 1987; 15:923–929
54. Sato R, Kuriyama A, Takada T, et al: Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study. Medicine (Baltimore) 2016; 95:e5031
55. 2 Collaborative Group. N Engl J Med 1995; 333:1025–1032
56. Baan J, Jong TT, Kerkhof PL, et al: Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res 1981; 15:328–334
57. Arthur W, Edgar D, Kaye GC: The measurement of impedance to assess myocardial contractility and rhythm stability. Physiol Meas 2000; 21:R43–R54
58. Burkhoff D, Mirsky I, Suga H: Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: A guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005; 289:H501–H512
59. Tei C, Ling LH, Hodge DO, et al: New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26:357–366
60. Wilhelm J, Hettwer S, Schuermann M, et al: Severity of cardiac impairment in the early stage of community-acquired sepsis determines worse prognosis. Clin Res Cardiol 2013; 102:735–744
61. Stanton T, Leano R, Marwick TH: Prediction of all-cause mortality from global longitudinal speckle strain: Comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2009; 2:356–364
62. Ng PY, Sin WC, Ng AK, et al: Speckle tracking echocardiography in patients with septic shock: A case control study (SPECKSS). Crit Care 2016; 20:145
63. Palmieri V, Innocenti F, Guzzo A, et al: Left ventricular systolic longitudinal function as predictor of outcome in patients with sepsis. Circ Cardiovasc Imaging 2015; 8:e003865
64. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126–131
65. Redl G, Germann P, Plattner H, et al: Right ventricular function in early septic shock states. Intensive Care Med 1993; 19:3–7
66. Dhainaut JF, Lanore JJ, de Gournay JM, et al: Right ventricular dysfunction in patients with septic shock. Intensive Care Med 1988; 14(Suppl 2):488–491
67. Chan CM, Klinger JR: The right ventricle in sepsis. Clin Chest Med 2008; 29:661–676, ix
68. Poelaert J, Declerck C, Vogelaers D, et al: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997; 23:553–560
69. Jafri SM, Lavine S, Field BE, et al: Left ventricular diastolic function in sepsis. Crit Care Med 1990; 18:709–714
70. Nagueh SF, Appleton CP, Gillebert TC, et al: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22:107–133
71. Ammann P, Fehr T, Minder EI, et al: Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27:965–969
72. Ostermann M, Ayis S, Tuddenham E, et al: Cardiac troponin release is associated with biomarkers of inflammation and ventricular dilatation during critical illness. Shock 2017; 47:702–708
73. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539–1553
74. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949–958
75. Pathan N, Franklin JL, Eleftherohorinou H, et al: Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase. Crit Care Med 2011; 39:1692–1711
76. Kumar A, Brar R, Wang P, et al: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999; 276(1 Pt 2):R265–R276
77. Tzeng HP, Fan J, Vallejo JG, et al: Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes. Am J Physiol Heart Circ Physiol 2008; 294:H1490–H1496
78. Haileselassie B, Su E, Pozios I, et al: Myocardial oxidative stress correlates with left ventricular dysfunction on strain echocardiography in a rodent model of sepsis. Intensive Care Med Exp 2017; 5:21
79. Freitas AC, Figueiredo MJ, Campos EC, et al: Activation of both the calpain and ubiquitin-proteasome systems contributes to septic cardiomyopathy through dystrophin loss/disruption and mTOR inhibition. PLoS One 2016; 11:e0166839
80. Martin L, Horst K, Chiazza F, et al: The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsis. Sci Rep 2016; 6:37277
81. Galley HF: Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011; 107:57–64
82. Joshi MS, Julian MW, Huff JE, et al: Calcineurin regulates myocardial function during acute endotoxemia. Am J Respir Crit Care Med 2006; 173:999–1007
83. Rossi MA, Celes MR, Prado CM, et al: Myocardial structural changes in long-term human severe sepsis/septic shock may be responsible for cardiac dysfunction. Shock 2007; 27:10–18
84. Soriano FG, Nogueira AC, Caldini EG, et al: Potential role of poly(adenosine 5’-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock. Crit Care Med 2006; 34:1073–1079
85. Mehta NJ, Khan IA, Gupta V, et al: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004; 95:13–17
86. Vincent JL, Gris P, Coffernils M, et al: Myocardial depression characterizes the fatal course of septic shock. Surgery 1992; 111:660–667
87. Liu D, Du B, Long Y, et al: Right ventricular function of patients with septic shock: clinical significance. Zhonghua Wai Ke Za Zhi 2000; 38:488–492
88. Ammann P, Maggiorini M, Bertel O, et al: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41:2004–2009
89. Røsjø H, Varpula M, Hagve TA, et al; FINNSEPSIS Study Group: Circulating high sensitivity troponin T in severe sepsis and septic shock: Distribution, associated factors, and relation to outcome. Intensive Care Med 2011; 37:77–85
90. Yucel T, Memiş D, Karamanlioglu B, et al: The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis. Exp Clin Cardiol 2008; 13:183–188
91. McLean AS, Huang SJ, Hyams S, et al: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35:1019–1026
92. Möckel M, Searle J, Maisel A: The role of procalcitonin in acute heart failure patients. ESC Heart Fail 2017; 4:203–208
93. Schuetz P, Daniels LB, Kulkarni P, et al: Procalcitonin: A new biomarker for the cardiologist. Int J Cardiol 2016; 223:390–397
94. Rennyson SL, Hunt J, Haley MW, et al: Electrocardiographic ST-segment elevation myocardial infarction in critically ill patients: An observational cohort analysis. Crit Care Med 2010; 38:2304–2309
95. Wang K, Asinger RW, Marriott HJ: ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003; 349:2128–2135
96. Ou SM, Chu H, Chao PW, et al: Long-term mortality and major adverse cardiovascular events in sepsis survivors. A nationwide population-based study. Am J Respir Crit Care Med 2016; 194:209–217
97. Yende S, Linde-Zwirble W, Mayr F, et al: Risk of cardiovascular events in survivors of severe sepsis. Am J Respir Crit Care Med 2014; 189:1065–1074
98. Rhodes A, Evans LE, Alhazzani W, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit Care Med 2017; 45:486–552
99. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368–1377
100. Pinto BB, Rehberg S, Ertmer C, et al: Role of levosimendan in sepsis and septic shock. Curr Opin Anaesthesiol 2008; 21:168–177
101. Gordon AC, Perkins GD, Singer M, et al: Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016; 375:1638–1648
102. Morelli A, Donati A, Ertmer C, et al: Microvascular effects of heart rate control with esmolol in patients with septic shock: A pilot study. Crit Care Med 2013; 41:2162–2168
103. Beesley SJ, Wilson EL, Lanspa M, et al: Persistent tachycardia and mortality in septic shock patients. Am J Respir Crit Care Med 2017; 195:A1899
104. Annane D, Vignon P, Renault A, et al; CATS Study Group: Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet 2007; 370:676–684
105. Jardin F, Brun-Ney D, Auvert B, et al: Sepsis-related cardiogenic shock. Crit Care Med 1990; 18:1055–1060.
106. Weil MH, Nishjima H: Cardiac output in bacterial shock. Am J Med 1978; 64:920–922
107. Semler MW, Rice TW: Sepsis resuscitation: Fluid choice and dose. Clin Chest Med 2016; 37:241–250
108. Ruth A, McCracken CE, Fortenberry JD, et al: Extracorporeal therapies in pediatric severe sepsis: Findings from the pediatric healthcare information system. Crit Care 2015; 19:397
109. MacLaren G, Butt W, Best D, et al: Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med 2011; 12:133–136
110. Bréchot N, Luyt CE, Schmidt M, et al: Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med 2013; 41:1616–1626
111. Huang CT, Tsai YJ, Tsai PR, et al: Extracorporeal membrane oxygenation resuscitation in adult patients with refractory septic shock. J Thorac Cardiovasc Surg 2013; 146:1041–1046
112. Ventetuolo CE, Muratore CS: Extracorporeal life support in critically ill adults. Am J Respir Crit Care Med 2014; 190:497–508
113. Vohra HA, Adamson L, Weeden DF, et al: Use of extracorporeal membrane oxygenation in the management of septic shock with severe cardiac dysfunction after Ravitch procedure. Ann Thorac Surg 2009; 87:e4–e5
114. Gabel E, Gudzenko V, Cruz D, et al: Successful use of extracorporeal membrane oxygenation in an adult patient with toxic shock-induced heart failure. J Intensive Care Med 2015; 30:115–118
115. MacLaren G, Pellegrino V, Butt W, et al: Successful use of ECMO in adults with life-threatening infections. Anaesth Intensive Care 2004; 32:707–710
116. Bruenger F, Kizner L, Weile J, et al: First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: A case report. Int J Artif Organs 2015; 38:113–116
117. Fujisaki N, Takahashi A, Arima T, et al: Successful treatment of Panton-Valentine leukocidin-expressing Staphylococcus aureusassociated pneumonia co-infected with influenza using extracorporeal membrane oxygenation. In Vivo 2014; 28:961–965
118. Firstenberg MS, Abel E, Blais D, et al: The use of extracorporeal membrane oxygenation in severe necrotizing soft tissue infections complicated by septic shock. Am Surg 2010; 76:1287–1289
119. Pořízka M, Kopecký P, Prskavec T, et al: Successful use of extra-corporeal membrane oxygenation in a patient with streptococcal sepsis: A case report and review of literature. Prague Med Rep 2015; 116:57–63
120. Takahashi K, Tanabe K, Ohnuki M, et al: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861–872
121. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138–150
122. Balik M, Rulisek J, Leden P, et al: Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr 2012; 124:552–556
123. Aronson D, Burger AJ: Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann Noninvasive Electrocardiol 2001; 6:98–106
124. Fiuzat M, Wojdyla D, Pina I, et al: Heart rate or beta-blocker dose? association with outcomes in ambulatory heart failure patients with systolic dysfunction: Results from the HF-ACTION trial. JACC Heart Fail 2016; 4:109–115
125. Bristow MR: Treatment of chronic heart failure with β-adrenergic receptor antagonists: A convergence of receptor pharmacology and clinical cardiology. Circ Res 2011; 109:1176–1194
126. Deutschman CS, Ahrens T, Cairns CB, et al; Critical Care Societies CollaborativeUSCIITG Task Force on Critical Care Research: Multisociety Task Force for Critical Care Research: Key issues and recommendations. Crit Care Med 2012; 40:254–260
127. Angus DC, Carlet J; 2002 Brussels Roundtable Participants: Surviving intensive care: A report from the 2002 Brussels Roundtable. Intensive Care Med 2003; 29:368–377
128. Needham DM, Davidson J, Cohen H, et al: Improving long-term outcomes after discharge from intensive care unit: Report from a stakeholders’ conference. Crit Care Med 2012; 40:502–509
129. st century. Ann Intern Med 2010; 153:204–205
130. Prescott HC, Langa KM, Liu V, et al: Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med 2014; 190:62–69
131. Prescott HC, Langa KM, Iwashyna TJ: Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions. JAMA 2015; 313:1055–1057
132. Iwashyna TJ, Ely EW, Smith DM, et al: Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010; 304:1787–1794
133. Corrales-Medina VF, Suh KN, Rose G, et al: Cardiac complications in patients with community-acquired pneumonia: A systematic review and meta-analysis of observational studies. PLoS Med 2011; 8:e1001048